ArticleNucleic acids research2025
Dynamics and structural features of the eEF1A1 and eEF1A2 paralogs.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting eEF1A1 With Baicalein to Block eEF1A1/Prdx4 Interaction for Treating Sepsis-Mediated Lung Injury.Exploration (Beijing, China) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The translation elongation factors eEF1A1 and eEF1A2 share 97% sequence similarity and perform similar roles in translation but exhibit mutually exclusive expression patterns in human tissues. Despite their high homology, they are linked to different diseases, likely due to paralog-specific interactions with distinct protein partners. The underlying reasons for these differences remain unclear. Here, using a combination of HDX-MS, MD, and SAXS approaches, we demonstrate that eEF1A1 and eEF1A2 exhibit distinct structural dynamics, leading to different structural organizations. eEF1A2 is a compact, stably folded protein, whereas eEF1A1 adopts multiple conformational states, including the opening and closing of the conformational space between domains D1 and D3, as well as significant internal and external dynamics of domain D2. These dynamics facilitate protein dimerization in eEF1A1, contrasting with eEF1A2, which apparently remains monomeric in solution, challenging previous X-ray crystallography findings. These data provide molecular insight into the functional differences between the highly homologous translation factors eEF1A1 and eEF1A2, potentially explaining their paralog-specific nontranslational roles and distinct contributions to human diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.